Jennifer Rymer, MD, MBA, MHSModeratorIntroductionsCangrelor in AMI & CS
Sarah Gorgis, MDPharmacodynamics of Antiplatelet Therapies in CS?
Upon completion of this activity, participants will be able to:
Examine the pharmacodynamic profile of parenteral antiplatelet agents.
Review current data on antiplatelet considerations in acute coronary syndrome and cardiogenic shock.
Describe contemporary antiplatelet treatment protocols in STEMI and cardiogenic shock.
Discuss future antiplatelet and antithrombotic therapeutic targets.
Accreditation StatementThe Society for Cardiovascular Angiography and Interventions (SCAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit DesignationSCAI designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOCSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.0 MOC points in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABIM MOC credit.
Successful CompletionWatch the content and complete the evaluation to obtain credit.Activity TimelineRecord Date: October 18, 2024Publish Date: November 18, 2024Retire Date: November 18, 2025